Source - LSE Regulatory
RNS Number : 6397I
Amryt Pharma PLC
13 August 2021
 

GENERAL TEXT AMENDMENT

 

The following amendment has been made to the Holding(s) in Company announcement released on 10th August at 9.53am under RNS No 1441I.

 

The shareholding percentage (but not the total shares) has been updated to reflect the pre-Warrant Share Admission number of ordinary shares outstanding as of August 5.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BKLTQ412

Issuer Name

AMRYT PHARMA PLC

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

Athyrium Funds GP Holdings LLC

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Athyrium Opportunities III Acquisition 2 LP

Wilmington

United States

Athyrium Opportunities II Acquisition 2 LP

Wilmington

United States

5. Date on which the threshold was crossed or reached

05-Aug-2021

6. Date on which Issuer notified

09-Aug-2021

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

14.420000

0.000000

14.420000

44286346

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BKLTQ412

0

44286346

0.000000

14.420000

Sub Total 8.A

44286346

14.420000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Jeffrey Ferrell

Athyrium Funds GP Holdings LLC

14.420000

0.000000

14.420000

Jeffrey Ferrell

Athyrium GP Holdings LLC

8.530000

0.000000

8.530000

Jeffrey Ferrell

Athyrium Opportunities Associates II LP

8.530000

0.000000

8.530000

Jeffrey Ferrell

Athyrium Opportunities II Acquisition 2 LP

8.530000

0.000000

8.530000

Jeffrey Ferrell

Athyrium Opportunities Associates III GP LLC

5.890000

0.000000

5.890000

Jeffrey Ferrell

Athyrium Opportunities Associates III LP

5.890000

0.000000

5.890000

Jeffrey Ferrell

Athyrium Opportunities III Acquisition 2 LP

5.890000

0.000000

5.890000

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

There are two chains of controlled undertakings, each controlled by Athyrium Funds GP Holdings LLC and, ultimately, Jeffrey Ferrell. As this was the first TR-1 report made through the ESS, there was a delay caused by registration. However, the Microsoft Word form of the notice was provided to the Issuer and the FCA email address on 09/08/2021.

12. Date of Completion

12-Aug-2021

13. Place Of Completion

New York, USA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUOSARAKUWAAR
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.